Physician profile
Ryan Moses
NPI 1467143503
$154.00
in general payments reported to CMS, 2019-2025
7 companies · $38.57 in 2025
The $38.57 reported for 2025 was less than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $115 · 2025: $38.57.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $154.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $154.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alexion Pharmaceuticals, INC. | $28.89 | 2024 | Ultomiris |
| Lexicon Pharmaceuticals, INC. | $27.71 | 2024 | |
| Lilly USA, LLC | $21.41 | 2024 | Retevmo, Jaypirca, Verzenio |
| Merck Sharp & Dohme LLC | $21.35 | 2025 | Prevymis, Zerbaxa |
| Astrazeneca Pharmaceuticals LP | $19.39 | 2024 | Calquence |
| Vertex Pharmaceuticals Incorporated | $18.03 | 2024 | |
| Bayer Healthcare Pharmaceuticals INC. | $17.22 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ryan Moses listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.